The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients.

CONCLUSION: The novel association of the disease state with tumoral and paratumoral immune cell signatures suggests new possibilities for personalized immunotherapy for EC patients.
PMID: 32447483 [PubMed - as supplied by publisher]

Source: Clin Med Res - May 22, 2020 Category: Research Authors: Strizova Z, Snajdauf M, Stakheev D, Taborska P, Vachtenheim J, Biskup J, Lischke R, Bartunkova J, Smrz D Tags: J Cancer Res Clin Oncol Source Type: research